1. Educational materials updated for valproate in the UK

   News item 29 February 2020 Pages: 1 - 1

2. EMA to regularly publish DHPCs on its website

   News item 29 February 2020 Pages: 2 - 2

3. Healthcare professionals can use EMIS Web to report ADRs to MHRA

   News item 29 February 2020 Pages: 3 - 3

4. MHRA launches social media campaign on reporting adverse effects

   News item 29 February 2020 Pages: 4 - 4

5. PRAC recommends cyproterone restrictions due to meningioma risk

   News item 29 February 2020 Pages: 5 - 5

6. Tofacitinib increases risk of VTE and serious infections

   News item 29 February 2020 Pages: 6 - 6

7. Toxicity of propranolol overdose under-recognised

   News item 29 February 2020 Pages: 7 - 7

8. Cardiovascular adverse events with contemporary cancer therapies

   Clinical study 29 February 2020 Pages: 8 - 8

9. Chlorthalidone, hydrochlorothiazide cardiovascular outcomes and safety

   Clinical study 29 February 2020 Pages: 9 - 9

10. Duloxetine increases risk of postpartum haemorrhage

    Clinical study 29 February 2020 Pages: 10 - 10

11. General anaesthesia linked with severe postpartum depression

    Clinical study 29 February 2020 Pages: 11 - 11

12. Low-dose methotrexate: risk of skin cancer and GI and pulmonary AEs

    Clinical study 29 February 2020 Pages: 12 - 12

13. Pregnancy and birth outcomes with MenACWY-CRM vaccine

    Clinical study 29 February 2020 Pages: 13 - 13

14. Other adverse reaction research

    News item 29 February 2020 Pages: 14 - 14

15. Aciclovir

    Case report 29 February 2020 Pages: 15 - 15

16. Adalimumab

    Case report 29 February 2020 Pages: 16 - 16

17. Adalimumab

    Case report 29 February 2020 Pages: 17 - 17

18. Adalimumab

    Case report 29 February 2020 Pages: 18 - 18

19. Adalimumab

    Case report 29 February 2020 Pages: 19 - 19

20. Adalimumab

    Case report 29 February 2020 Pages: 20 - 20

21. Adalimumab

    Case report 29 February 2020 Pages: 21 - 21

22. Adalimumab/infliximab

    Case report 29 February 2020 Pages: 22 - 22

23. Adalimumab/prednisone

    Case report 29 February 2020 Pages: 23 - 23

24. Adefovir/teriparatide

    Case report 29 February 2020 Pages: 24 - 24

25. Alemtuzumab

    Case report 29 February 2020 Pages: 25 - 25

26. Allopurinol

    Case report 29 February 2020 Pages: 26 - 26

27. Allopurinol

    Case report 29 February 2020 Pages: 27 - 27

28. Allopurinol

    Case report 29 February 2020 Pages: 28 - 28

29. Allopurinol/everolimus/prednisolone

    Case report 29 February 2020 Pages: 29 - 29

30. Allopurinol/mercaptopurine interaction

    Case report 29 February 2020 Pages: 30 - 30

31. Alteplase

    Case report 29 February 2020 Pages: 31 - 31

32. Alteplase

    Case report 29 February 2020 Pages: 32 - 32

33. Amikacin/ceftriaxone/metronidazole

    Case report 29 February 2020 Pages: 33 - 33

34. Amiodarone

    Case report 29 February 2020 Pages: 34 - 34

35. Amiodarone

    Case report 29 February 2020 Pages: 35 - 35

36. Amiodarone

    Case report 29 February 2020 Pages: 36 - 36

37. Amiodarone

    Case report 29 February 2020 Pages: 37 - 37

38. Amiodarone/flecainide/sodium-bicarbonate

    Case report 29 February 2020 Pages: 38 - 38

39. Amoxicillin

    Case report 29 February 2020 Pages: 39 - 39

40. Amoxicillin

    Case report 29 February 2020 Pages: 40 - 40

41. Amoxicillin/clavulanic-acid

    Case report 29 February 2020 Pages: 41 - 41

42. Amoxicillin/clavulanic-acid

    Case report 29 February 2020 Pages: 42 - 42

43. Amoxicillin/clavulanic-acid

    Case report 29 February 2020 Pages: 43 - 43

44. Amoxicillin/clavulanic-acid/rifampicin

    Case report 29 February 2020 Pages: 44 - 44

45. Amoxicillin/cotrimoxazole

    Case report 29 February 2020 Pages: 45 - 45

46. Amphetamines/serotonin-uptake-inhibitors

    Case report 29 February 2020 Pages: 46 - 46

47. Amrubicin

    Case report 29 February 2020 Pages: 47 - 47

48. Anabolic steroids abuse

    Case report 29 February 2020 Pages: 48 - 48

49. Anastrozole

    Case report 29 February 2020 Pages: 49 - 49

50. Antiarrhythmics/antineoplastics

    Case report 29 February 2020 Pages: 50 - 50